Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript

NBIX earnings call for the period ending September 30, 2021.

Related Keywords

United States ,America ,Morgan Stanley ,Todd Tushla ,Josh Schimmer Evercore ,Chris Shibutani ,Eiryw Roberts ,Paul Matteis Stifel ,Kyle Gano ,Myles Minter William Blair ,Phil Nadeau Cowen ,Carter Gould Barclays ,Josh Schimmer ,Laura Chico ,Piper Sandler ,Eddie Hickman Guggenheim ,Matthewc Abernethy ,Phil Nadeau ,Brian Skorney Baird ,Eric Benevich ,William Blair ,Neena Bitritto Garg ,Anupam Rama ,Charles Duncan ,Kevinc Gorman ,Charles Duncan Cantor Fitzgerald ,Carter Gould ,Laura Chico Wedbush ,Paul Matteis ,Matt Abernethy ,Brian Abrahams ,Brian Skorney ,Myles Minter ,Yatin Suneja ,Eiry Roberts ,Kelly Shi Jefferies ,Chris Shibutani Goldman Sachs ,David Amsellem ,David Amsellem Piper Sandler ,Tazeen Ahmad ,Kelly Shi ,Kevin Gorman ,Neurocrine Biosciences Inc ,Psych Congress ,Goldman Sachs ,Cantor Fitzgerald ,Company Analyst ,Barclays ,Tazeen Ahmad Bank ,Business Development ,Neurocrine Biosciences ,Neurocrine Biosciences Reports Third Quarter ,Vice President ,Investor Relations ,Chief Executive Officer ,Chief Financial Officer ,Chief Medical Officer ,Chief Commercial Officer ,Chief Business Development ,Tardive Dyskinesia Impact Scale ,Clinical Global Impression Severity Score ,Social Performance ,Jeff Hung ,Ami Fadia ,Vamil Divan ,Mizuho Securities ,